Charles River Laboratories International Depreciation & Amortization 2011-2026 | CRL

Annual Depreciation & Amortization Charles River Laboratories International

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
403 M	362 M	314 M	304 M	266 M	235 M	198 M	162 M	131 M	127 M	94.9 M	96.4 M	96.6 M	81.3 M	85.2 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
403 M	81.3 M	197 M

Quarterly Depreciation & Amortization Charles River Laboratories International

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
85.2 M	120 M	120 M	-	88.2 M	86.1 M	85.4 M	-	78.9 M	77.7 M	77.1 M	-	74.6 M	76.4 M	75.3 M	-	68.7 M	68.1 M	61.5 M	-	59.6 M	57.2 M	57.3 M	-	51.8 M	49.1 M	45.4 M	-	43.6 M	43.4 M	33.2 M	-	33.5 M	31.8 M	32.4 M	-	34.1 M	32.4 M	24.7 M	-	23.8 M	23.1 M	22.4 M	-	26.1 M	24.3 M	20 M	-	67.3 M	40.4 M	20 M	-	60.6 M	40.1 M	20 M	-	64.2 M	43.1 M	21.3 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
120 M	20 M	53.1 M

Depreciation & Amortization of other stocks in the Diagnostics research industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Agilent Technologies A	321 M	$ 115.35	-2.33 %	$ 35.1 B	USA
Anixa Biosciences ANIX	38.3 K	$ 2.81	-2.7 %	$ 91.2 K	USA
Akumin AKU	98.2 M	-	-17.87 %	$ 25.9 M	Canada
Check-Cap Ltd. CHEK	161 K	-	-	$ 9.42 M	Israel
Aspira Women's Health AWH	264 K	-	-6.19 %	$ 10.5 M	USA
Burning Rock Biotech Limited BNR	47.8 M	$ 22.48	-1.58 %	$ 234 M	China
Bioventus BVS	47 M	$ 8.45	-7.14 %	$ 563 M	USA
Celcuity CELC	130 K	$ 114.85	-0.34 %	$ 4.53 B	USA
Castle Biosciences CSTL	16 M	$ 27.23	-2.44 %	$ 756 M	USA
DermTech DMTK	200 K	-	-11.32 %	$ 2.94 M	USA
Co-Diagnostics CODX	1.23 M	-	-	$ 79.8 M	USA
Fulgent Genetics FLGT	24.9 M	$ 14.59	2.41 %	$ 441 M	USA
Accelerate Diagnostics AXDX	1.7 M	-	-61.36 %	$ 2.46 M	USA
Global Cord Blood Corporation CO	43.3 M	-	-	$ 399 M	China
Biodesix BDSX	5.77 M	$ 18.61	17.37 %	$ 2.41 B	USA
Biocept BIOC	1.66 M	-	-13.05 %	$ 7.29 M	USA
Illumina ILMN	354 M	$ 124.76	-2.71 %	$ 19.8 B	USA
IQVIA Holdings IQV	1.14 B	$ 175.33	-1.8 %	$ 30.1 B	USA
BioNano Genomics BNGO	14 M	$ 1.11	-1.36 %	$ 1.41 M	USA
Heska Corporation HSKA	14 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	587 K	-	-20.0 %	$ 1.06 M	USA
Quest Diagnostics Incorporated DGX	570 M	$ 199.8	-2.07 %	$ 22.2 B	USA
Danaher Corporation DHR	750 M	$ 195.75	-2.99 %	$ 140 B	USA
IDEXX Laboratories IDXX	145 M	$ 607.19	-1.9 %	$ 48.8 B	USA
Exact Sciences Corporation EXAS	125 M	$ 103.5	0.17 %	$ 19.5 B	USA
DarioHealth Corp. DRIO	473 K	$ 9.69	-3.0 %	$ 275 M	Israel
Laboratory Corporation of America Holdings LH	681 M	$ 269.52	-2.34 %	$ 22.4 B	USA
DexCom DXCM	252 M	$ 68.5	-3.1 %	$ 26.7 B	USA
QIAGEN N.V. QGEN	203 M	-	-	$ 10.6 B	Niderland
ICON Public Limited Company ICLR	488 M	$ 107.08	-3.19 %	$ 8.83 B	Irlanda
Lantheus Holdings LNTH	70.1 M	$ 72.86	-4.53 %	$ 4.92 B	USA
CareDx, Inc CDNA	15 M	$ 17.91	-4.48 %	$ 954 M	USA
Chembio Diagnostics CEMI	2.55 M	-	0.22 %	$ 16.8 M	USA
Mettler-Toledo International MTD	51.1 M	$ 1 215.85	-3.66 %	$ 25.1 B	Schweiz
Myriad Genetics MYGN	53.7 M	$ 5.15	0.29 %	$ 477 M	USA
NeoGenomics NEO	36.1 M	$ 8.92	-2.3 %	$ 1.14 B	USA
National Research Corporation NRC	7.62 M	$ 14.48	3.13 %	$ 324 M	USA
Guardant Health GH	39.7 M	$ 91.56	-1.1 %	$ 11.5 B	USA
Natera NTRA	16.7 M	$ 196.94	-0.1 %	$ 19.4 B	USA
Motus GI Holdings MOTS	451 K	-	-34.28 %	$ 263 K	Israel
OPKO Health OPK	98.2 M	$ 1.18	0.43 %	$ 819 M	USA
Enzo Biochem ENZ	1.27 M	-	-8.98 %	$ 14.8 K	USA